Lab monitoring on Addyi: which tests and how often
Many chronic medications including Addyi (Flibanserin) come with a recommended laboratory monitoring schedule — baseline labs before starting, follow-up checks at defined intervals, and additional tests if symptoms or risk factors change. Knowing what is monitored, why and how often takes the mystery out of routine appointments at 100mg.
Tests typically monitored on Addyi
According to the prescribing information for Flibanserin, the standard monitoring panel for Addyi usually includes: liver function (ALT, AST), kidney function (creatinine, eGFR), electrolytes (potassium, sodium), and any class-specific markers (e.g. lipid panel, glucose, hormone levels, blood counts) relevant to Women's Sexual Health. Sexual desire is modulated by complex central nervous system pathways involving serotonin (generally inhibitory) and dopamine and norepinephrine (generally excitatory).
Frequency and triggers
Baseline labs before starting Addyi establish the reference. Follow-up at 4–12 weeks is typical for most chronic medications, then annually if stable. More frequent monitoring is triggered by dose changes, new symptoms, intercurrent illness, or other interacting medications added to the regimen at 100mg.
Frequently asked questions
How often do I need blood tests on Addyi? ▾
Most users have baseline labs before starting Addyi at 100mg, follow-up at a few weeks to a few months, and then annually if stable. Frequency increases with dose changes, side effects or comorbidities. The prescriber sets the schedule.
What does the doctor look for in my Addyi bloodwork? ▾
The prescriber checks that liver and kidney function are stable, electrolytes are in range, and any class-specific markers (depending on Flibanserin) remain within expected boundaries. Trend over time matters more than any single value.
More on Addyi
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.